Daxor Announces Union Hospital of Cecil County, MD Acquires BVA-100 Blood Volume Analyzer

NEW YORK, NY -- (MARKET WIRE) -- April 25, 2007 -- Daxor Corporation (AMEX: DXR), a medical instrumentation and biotechnology company, today announced the receipt of a signed trial agreement from Union Hospital of Elkton, Maryland.

Since 1908, Union Hospital has provided quality health and wellness services to residents in Maryland, Delaware and Pennsylvania. As a 121-bed state-of-the-art not-for-profit hospital, Union Hospital is the leading provider in the areas of inpatient, outpatient and emergency services, a comprehensive health education program and a team that includes about 260 physicians and 900 staff members. With the recent addition of its new inpatient tower, renovations to the pediatric unit and an expanded intensive care unit for patients needing specialized care, Union Hospital continues to demonstrate its commitment to ensuring high quality state-of-the-art health care.

Daxor's Blood Volume Analyzer BVA-100 will be located within Union Hospital's Nuclear Medicine Department, and will be utilized to diagnose patient blood volume derangements in various medical conditions and disease states.

Published medical articles have shown that current practices to clinically assess a heart failure patient's intravascular blood volume without a blood volume measurement are only accurate 50% of the time. The treatment of a heart failure patient's intravascular blood volume to euvolemia (normovolemia) is of primary importance according to the most recent Heart Failure Guidelines. In one two-year study, patients who were treated to euvolemia had a 100% survival rate, versus a 55% death rate (or need for urgent transplant) in patients who were not treated to euvolemia. In the intensive care unit, clinical investigations have shown that the integration of blood volume measurements changed fluid and transfusion management in 36% of the cases. Daxor's Blood Volume Analyzer BVA-100 is the only FDA approved diagnostic device which provides for a 98% accurate measurement of blood volume.

Other nationally renowned hospitals which have purchased the BVA-100 Blood Volume Analyzer after using it on a clinical trial basis are The Mayo Clinic, The Cleveland Clinic, and New York University Medical Center. Daxor Corporation manufactures and markets the BVA-100, a semi-automated Blood Volume Analyzer. The BVA-100 is used in conjunction with Volumex, Daxor's single use diagnostic kit. For more information regarding Daxor Corporation's Blood Volume Analyzer BVA-100, visit Daxor's website www.Daxor.com.

Contact Information: Contact Information: Stephen Feldschuh Chief Operating Officer 212-330-8515 Email Contact Diane Meegan Investor Relations 212-330-8512 Email Contact